Standout Papers
- Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study (2011)
- Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome–positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance (2007)
- American Society of Clinical Oncology Statement: Achieving High-Quality Cancer Survivorship Care (2013)
Immediate Impact
3 by Nobel laureates 9 from Science/Nature 84 standout
Citing Papers
T-cell-engaging bispecific antibodies in cancer
2023 Standout
In vivo hematopoietic stem cell modification by mRNA delivery
2023 StandoutScienceNobel
Works of Ravi Bhatia being referenced
Preliminary Results from a Phase 1 First-in-Human Study of AMG 673, a Novel Half-Life Extended (HLE) Anti-CD33/CD3 BiTE® (Bispecific T-Cell Engager) in Patients with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)
2019
Bone mineral density in patients undergoing bone marrow transplantation for myeloid malignancies
1998
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Ravi Bhatia | 8749 | 4389 | 4333 | 5733 | 4683 | 453 | 21.2k | |
| Stephanie J. Lee | 15379 | 6570 | 3887 | 5577 | 2839 | 620 | 25.2k | |
| Peter H. Wiernik | 6322 | 3306 | 1023 | 7004 | 5161 | 505 | 19.4k | |
| Mark R. Litzow | 11567 | 4715 | 1498 | 4678 | 5368 | 585 | 18.3k | |
| Stephen J. Forman | 12044 | 4670 | 2327 | 15823 | 7901 | 850 | 35.1k | |
| Raul C. Ribeiro | 6904 | 8642 | 5790 | 4232 | 4397 | 419 | 19.1k | |
| Stella M. Davies | 8538 | 4202 | 3317 | 3521 | 3160 | 508 | 17.5k | |
| Rob Pieters | 7793 | 11166 | 6176 | 4063 | 9112 | 515 | 22.3k | |
| Gerhard Ehninger | 13344 | 3743 | 1016 | 6426 | 6007 | 677 | 24.5k | |
| Joseph H. Antin | 17464 | 4126 | 2033 | 6240 | 2609 | 489 | 27.5k | |
| Robert Peter Gale | 14244 | 3814 | 1297 | 5515 | 3645 | 598 | 23.5k |
All Works
Login with ORCID to disown or claim papers
Loading papers...